Literature DB >> 16398778

Chronic fetal hypoxia increases activin A concentrations in the late-pregnant sheep.

V G Supramaniam1, G Jenkin, J Loose, E M Wallace, S L Miller.   

Abstract

OBJECTIVE: To determine whether activin A concentrations are altered in chronic fetal hypoxemia and intrauterine fetal growth restriction (IUGR).
DESIGN: In vivo animal experimental model.
SETTING: Department of Physiology, Monash University. POPULATION: Chronically catherised fetal sheep in late pregnancy.
METHODS: Chronic fetal hypoxia and IUGR were experimentally induced by single umbilical artery ligation (SUAL) in catheterised fetal sheep. Maternal and fetal blood samples and amniotic fluid (AF) samples were collected during surgery and thereafter on alternate days, until the time of delivery for analyte measurement. Fetal blood gas parameters were measured daily. MAIN OUTCOME MEASURES: Plasma and AF was used to analyse activin A, prostaglandin E2 (PGE2) and cortisol and fetal blood gas analysis was undertaken in whole blood.
RESULTS: SUAL produced asymmetric IUGR and non-acidaemic chronic fetal hypoxia and resulted in preterm labour (129 [3] days). AF activin A concentrations were 10-fold higher in the SUAL group than in controls whereas levels in the fetal and maternal circulations were similar between groups.
CONCLUSIONS: SUAL-induced IUGR and fetal hypoxaemia increases AF activin A. This may be an important adaptive or protective response to IUGR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16398778     DOI: 10.1111/j.1471-0528.2005.00791.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  16 in total

Review 1.  Intrauterine Growth Restriction: Hungry for an Answer.

Authors:  Sherin U Devaskar; Alison Chu
Journal:  Physiology (Bethesda)       Date:  2016-03

2.  Altered cardiovascular function at birth in growth-restricted preterm lambs.

Authors:  Graeme R Polglase; Beth J Allison; Elise Coia; Anqi Li; Graham Jenkin; Atul Malhotra; Arvind Sehgal; Martin Kluckow; Andrew W Gill; Stuart B Hooper; Suzanne L Miller
Journal:  Pediatr Res       Date:  2016-05-16       Impact factor: 3.756

Review 3.  Antenatal prevention of cerebral palsy and childhood disability: is the impossible possible?

Authors:  Stacey J Ellery; Meredith Kelleher; Peta Grigsby; Irina Burd; Jan B Derks; Jon Hirst; Suzanne L Miller; Larry S Sherman; Mary Tolcos; David W Walker
Journal:  J Physiol       Date:  2018-07-21       Impact factor: 5.182

Review 4.  Animal models for small for gestational age and fetal programming of adult disease.

Authors:  Patricia M Vuguin
Journal:  Horm Res       Date:  2007-03-09

5.  Partial pulmonary embolization disrupts alveolarization in fetal sheep.

Authors:  Caitlin E Filby; Stuart B Hooper; Megan J Wallace
Journal:  Respir Res       Date:  2010-04-23

Review 6.  The consequences of fetal growth restriction on brain structure and neurodevelopmental outcome.

Authors:  Suzanne L Miller; Petra S Huppi; Carina Mallard
Journal:  J Physiol       Date:  2016-01-05       Impact factor: 5.182

Review 7.  Role of melatonin in embryo fetal development.

Authors:  S E Voiculescu; N Zygouropoulos; C D Zahiu; A M Zagrean
Journal:  J Med Life       Date:  2014 Oct-Dec

8.  Comparison of fetal middle cerebral arteries, umbilical and uterin artery color Doppler ultrasound with blood gas analysis in pregnancy complicated by IUGR.

Authors:  Zahra Fardiazar; Simin Atashkhouei; Yousef Yosefzad; Mohamad Goldust; Reza Torab
Journal:  Iran J Reprod Med       Date:  2013-01

Review 9.  Dimming the Powerhouse: Mitochondrial Dysfunction in the Liver and Skeletal Muscle of Intrauterine Growth Restricted Fetuses.

Authors:  Alexander L Pendleton; Stephanie R Wesolowski; Timothy R H Regnault; Ronald M Lynch; Sean W Limesand
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-17       Impact factor: 5.555

10.  Antenatal melatonin as an antioxidant in human pregnancies complicated by fetal growth restriction--a phase I pilot clinical trial: study protocol.

Authors:  Nicole O Alers; Graham Jenkin; Suzanne L Miller; Euan M Wallace
Journal:  BMJ Open       Date:  2013-12-23       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.